Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Lessons learnt from establishing a high dose opioid review clinic for people living with HIV.

Laycock H, Crawford V, Rice AS, Cox S.

Pain Manag. 2018 Dec 3. doi: 10.2217/pmt-2018-0041. [Epub ahead of print]

PMID:
30501569
2.

Kyrle Disease.

Rice AS, Zedek D.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.

3.

Dowling Degos Disease.

Rice AS, Cook C.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.

4.

Up-date on Clinical Management of Postherpetic Neuralgia and Mechanism-Based Treatment: New Options in Therapy.

Forstenpointner J, Rice ASC, Finnerup NB, Baron R.

J Infect Dis. 2018 Sep 22;218(suppl_2):S120-S126. doi: 10.1093/infdis/jiy381.

PMID:
30247597
5.

Psychosocial factors associated with persistent pain in people with HIV: a systematic review with meta-analysis.

Scott W, Arkuter C, Kioskli K, Kemp H, McCracken LM, Rice ASC, de C Williams AC.

Pain. 2018 Dec;159(12):2461-2476. doi: 10.1097/j.pain.0000000000001369.

6.

Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy.

Finnerup NB, Haroutounian S, Baron R, Dworkin RH, Gilron I, Haanpaa M, Jensen TS, Kamerman PR, McNicol E, Moore A, Raja SN, Andersen NT, Sena ES, Smith BH, Rice ASC, Attal N.

Pain. 2018 Nov;159(11):2339-2346. doi: 10.1097/j.pain.0000000000001340.

PMID:
30015707
7.

Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis.

Patel KV, Allen R, Burke L, Farrar JT, Gewandter JS, Gilron I, Katz NP, Markman JD, Marshall SF, Resnick M, Rice ASC, Rowbotham MC, Smith SM, Vanhove GF, Wasan AD, Zhang S, Dworkin RH, Turk DC.

Pain. 2018 Nov;159(11):2245-2254. doi: 10.1097/j.pain.0000000000001324.

PMID:
30001225
8.

Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy.

Wodarski R, Bagdas D, Paris JJ, Pheby T, Toma W, Xu R, Damaj MI, Knapp PE, Rice ASC, Hauser KF.

Pain Rep. 2018 May 14;3(3):e654. doi: 10.1097/PR9.0000000000000654. eCollection 2018 May.

9.

Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patients.

Sieberg CB, Taras C, Gomaa A, Nickerson C, Wong C, Ward C, Baskozos G, Bennett DLH, Ramirez JD, Themistocleous AC, Rice ASC, Shillo PR, Tesfaye S, Edwards RR, Andrews NA, Berde C, Costigan M.

Pain Rep. 2018 May 24;3(3):e651. doi: 10.1097/PR9.0000000000000651. eCollection 2018 May.

10.

Reply.

Rice ASC, Finnerup NB, Kemp HI, Currie GL, Baron R.

Pain. 2018 Jul;159(7):1428-1429. doi: 10.1097/j.pain.0000000000001249. No abstract available.

PMID:
29916962
11.

Transparency in the reporting of in vivo pre-clinical pain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines.

Rice ASC, Morland R, Huang W, Currie GL, Sena ES, Macleod MR.

Scand J Pain. 2013 Apr 1;4(2):58-62. doi: 10.1016/j.sjpain.2013.02.002.

PMID:
29913900
12.

Experimental design and reporting standards for improving the internal validity of pre-clinical studies in the field of pain: Consensus of the IMI-Europain consortium.

Knopp KL, Stenfors C, Baastrup C, Bannon AW, Calvo M, Caspani O, Currie G, Finnerup NB, Huang W, Kennedy JD, Lefevre I, Machin I, Macleod M, Rees H, Rice ASC, Rutten K, Segerdahl M, Serra J, Wodarski R, Berge OG, Treede RD.

Scand J Pain. 2015 Apr 1;7(1):58-70. doi: 10.1016/j.sjpain.2015.01.006.

PMID:
29911603
13.

Reply.

Kosek E, Cohen M, Baron R, Mico JA, Rice ASC.

Pain. 2018 Jun;159(6):1177-1178. doi: 10.1097/j.pain.0000000000001185. No abstract available.

PMID:
29768306
14.

Human T-lymphotrophic virus-a neglected cause of chronic pain?

Kemp HI, Rice ASC, Adonis A, Davies NWS, Taylor GP.

Pain. 2018 Aug;159(8):1433-1437. doi: 10.1097/j.pain.0000000000001214. No abstract available.

PMID:
29554019
15.

Reply: Non-freezing cold injury: a multi-faceted syndrome.

Vale TA, Symmonds M, Polydefkis M, Byrnes K, Rice ASC, Themistocleous AC, Bennett DLH.

Brain. 2018 Feb 1;141(2):e10. doi: 10.1093/brain/awx325. No abstract available.

PMID:
29315377
16.

Sensory profiling in animal models of neuropathic pain: a call for back-translation.

Rice ASC, Finnerup NB, Kemp HI, Currie GL, Baron R.

Pain. 2018 May;159(5):819-824. doi: 10.1097/j.pain.0000000000001138. No abstract available.

PMID:
29300280
17.

Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy.

Blesneac I, Themistocleous AC, Fratter C, Conrad LJ, Ramirez JD, Cox JJ, Tesfaye S, Shillo PR, Rice ASC, Tucker SJ, Bennett DLH.

Pain. 2018 Mar;159(3):469-480. doi: 10.1097/j.pain.0000000000001116.

18.

Chronic non-freezing cold injury results in neuropathic pain due to a sensory neuropathy.

Vale TA, Symmonds M, Polydefkis M, Byrnes K, Rice ASC, Themistocleous AC, Bennett DLH.

Brain. 2017 Oct 1;140(10):2557-2569. doi: 10.1093/brain/awx215.

19.

Reply.

Kosek E, Cohen M, Baron R, Mico JA, Rice ASC.

Pain. 2017 Jul;158(7):1396. doi: 10.1097/j.pain.0000000000000883. No abstract available.

PMID:
28622276
20.

Gabapentin for chronic neuropathic pain in adults.

Wiffen PJ, Derry S, Bell RF, Rice AS, Tölle TR, Phillips T, Moore RA.

Cochrane Database Syst Rev. 2017 Jun 9;6:CD007938. doi: 10.1002/14651858.CD007938.pub4. Review.

21.

Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations.

Vollert J, Maier C, Attal N, Bennett DLH, Bouhassira D, Enax-Krumova EK, Finnerup NB, Freynhagen R, Gierthmühlen J, Haanpää M, Hansson P, Hüllemann P, Jensen TS, Magerl W, Ramirez JD, Rice ASC, Schuh-Hofer S, Segerdahl M, Serra J, Shillo PR, Sindrup S, Tesfaye S, Themistocleous AC, Tölle TR, Treede RD, Baron R.

Pain. 2017 Aug;158(8):1446-1455. doi: 10.1097/j.pain.0000000000000935.

22.

Use of Corneal Confocal Microscopy to Evaluate Small Nerve Fibers in Patients With Human Immunodeficiency Virus.

Kemp HI, Petropoulos IN, Rice ASC, Vollert J, Maier C, Sturm D, Schargus M, Peto T, Hau S, Chopra R, Malik RA.

JAMA Ophthalmol. 2017 Jul 1;135(7):795-800. doi: 10.1001/jamaophthalmol.2017.1703.

23.

Reply.

Andresen SR, Hansen RM, Biering-Sørensen F, Hagen EM, Rice AS, Bach FW, Finnerup NB.

Pain. 2017 Apr;158(4):764-765. doi: 10.1097/j.pain.0000000000000822. No abstract available.

PMID:
28301406
24.

The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, Borsook D, Edwards RR, Harris RE, Wager TD, Arendt-Nielsen L, Burke LB, Carr DB, Chappell A, Farrar JT, Freeman R, Gilron I, Goli V, Haeussler J, Jensen T, Katz NP, Kent J, Kopecky EA, Lee DA, Maixner W, Markman JD, McArthur JC, McDermott MP, Parvathenani L, Raja SN, Rappaport BA, Rice ASC, Rowbotham MC, Tobias JK, Wasan AD, Witter J.

J Pain. 2017 Jul;18(7):757-777. doi: 10.1016/j.jpain.2017.02.429. Epub 2017 Feb 27. Review.

25.

Topical capsaicin (high concentration) for chronic neuropathic pain in adults.

Derry S, Rice AS, Cole P, Tan T, Moore RA.

Cochrane Database Syst Rev. 2017 Jan 13;1:CD007393. doi: 10.1002/14651858.CD007393.pub4. Review.

26.

Flight Lieutenant Peach's observations on Burning Feet Syndrome in Far Eastern Prisoners of War 1942-45.

Roocroft NT, Mayhew E, Parkes M, Frankland AW, Gill GV, Bouhassira D, Rice AS.

QJM. 2017 Mar 1;110(3):131-139. doi: 10.1093/qjmed/hcw195.

27.

Reply.

Kosek E, Cohen M, Baron R, Mico JA, Rice AS.

Pain. 2017 Jan;158(1):180. No abstract available.

PMID:
27984529
28.

Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles.

Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G, Finnerup NB, Haanpää M, Hansson P, Hüllemann P, Jensen TS, Freynhagen R, Kennedy JD, Magerl W, Mainka T, Reimer M, Rice AS, Segerdahl M, Serra J, Sindrup S, Sommer C, Tölle T, Vollert J, Treede RD.

Pain. 2017 Feb;158(2):261-272. doi: 10.1097/j.pain.0000000000000753.

29.

Reply.

Cohen M, Kosek E, Baron R, Mico JA, Rice AS.

Pain. 2016 Dec;157(12):2876-2877. No abstract available.

PMID:
27841843
30.

Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre study.

Wodarski R, Delaney A, Ultenius C, Morland R, Andrews N, Baastrup C, Bryden LA, Caspani O, Christoph T, Gardiner NJ, Huang W, Kennedy JD, Koyama S, Li D, Ligocki M, Lindsten A, Machin I, Pekcec A, Robens A, Rotariu SM, VoB S, Segerdahl M, Stenfors C, Svensson CI, Treede RD, Uto K, Yamamoto K, Rutten K, Rice AS.

Pain. 2016 Oct;157(10):2350-2365.

PMID:
27820160
31.

Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.

Boylan B, Rice AS, Neff AT, Manco-Johnson MJ, Kempton CL, Miller CH; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2016 Oct;14(10):1931-1940. doi: 10.1111/jth.13438. Epub 2016 Sep 17.

32.

Development, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study Settings.

Woldeamanuel YW, Kamerman PR, Veliotes DG, Phillips TJ, Asboe D, Boffito M, Rice AS.

PLoS One. 2016 Oct 20;11(10):e0164994. doi: 10.1371/journal.pone.0164994. eCollection 2016.

33.

Reliability of conditioned pain modulation: a systematic review.

Kennedy DL, Kemp HI, Ridout D, Yarnitsky D, Rice AS.

Pain. 2016 Nov;157(11):2410-2419. Review.

34.

A rodent model of HIV protease inhibitor indinavir induced peripheral neuropathy.

Huang W, Calvo M, Pheby T, Bennett DL, Rice AS.

Pain. 2017 Jan;158(1):75-85.

35.

Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre study.

Wodarski R, Delaney A, Ultenius C, Morland R, Andrews N, Baastrup C, Bryden LA, Caspani O, Christoph T, Gardiner NJ, Huang W, Kennedy JD, Koyama S, Li D, Ligocki M, Lindsten A, Machin I, Pekcec A, Robens A, Rotariu SM, Vo S, Segerdahl M, Stenfors C, Svensson CI, Treede RD, Uto K, Yamamoto K, Rutten K, Rice AS.

Pain. 2016 Oct;157(10):2350-65. doi: 10.1097/j.pain.0000000000000657.

36.

Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial.

Andresen SR, Bing J, Hansen RM, Biering-Sørensen F, Johannesen IL, Hagen EM, Rice AS, Nielsen JF, Bach FW, Finnerup NB.

Pain. 2016 Sep;157(9):2097-103. doi: 10.1097/j.pain.0000000000000623.

37.

Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.

Edwards RR, Dworkin RH, Turk DC, Angst MS, Dionne R, Freeman R, Hansson P, Haroutounian S, Arendt-Nielsen L, Attal N, Baron R, Brell J, Bujanover S, Burke LB, Carr D, Chappell AS, Cowan P, Etropolski M, Fillingim RB, Gewandter JS, Katz NP, Kopecky EA, Markman JD, Nomikos G, Porter L, Rappaport BA, Rice AS, Scavone JM, Scholz J, Simon LS, Smith SM, Tobias J, Tockarshewsky T, Veasley C, Versavel M, Wasan AD, Wen W, Yarnitsky D.

Pain. 2016 Sep;157(9):1851-71. doi: 10.1097/j.pain.0000000000000602. Review.

38.

Neuropathic pain: an updated grading system for research and clinical practice.

Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, Raja SN, Rice AS, Serra J, Smith BH, Treede RD, Jensen TS.

Pain. 2016 Aug;157(8):1599-606. doi: 10.1097/j.pain.0000000000000492. Review.

39.

The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy.

Themistocleous AC, Ramirez JD, Shillo PR, Lees JG, Selvarajah D, Orengo C, Tesfaye S, Rice AS, Bennett DL.

Pain. 2016 May;157(5):1132-45. doi: 10.1097/j.pain.0000000000000491.

40.

Enhanced c-Fos expression in the central amygdala correlates with increased thigmotaxis in rats with peripheral nerve injury.

Morland RH, Novejarque A, Spicer C, Pheby T, Rice AS.

Eur J Pain. 2016 Aug;20(7):1140-54. doi: 10.1002/ejp.839. Epub 2016 Mar 31.

41.

Do we need a third mechanistic descriptor for chronic pain states?

Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice AS, Rief W, Sluka AK.

Pain. 2016 Jul;157(7):1382-6. doi: 10.1097/j.pain.0000000000000507. Review. No abstract available.

PMID:
26835783
42.

Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies.

Smith MT, Anand P, Rice AS.

Pain. 2016 Feb;157 Suppl 1:S33-41. doi: 10.1097/j.pain.0000000000000369. Review.

PMID:
26785154
43.

Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.

Andrews NA, Latrémolière A, Basbaum AI, Mogil JS, Porreca F, Rice AS, Woolf CJ, Currie GL, Dworkin RH, Eisenach JC, Evans S, Gewandter JS, Gover TD, Handwerker H, Huang W, Iyengar S, Jensen MP, Kennedy JD, Lee N, Levine J, Lidster K, Machin I, McDermott MP, McMahon SB, Price TJ, Ross SE, Scherrer G, Seal RP, Sena ES, Silva E, Stone L, Svensson CI, Turk DC, Whiteside G.

Pain. 2016 Apr;157(4):901-9. doi: 10.1097/j.pain.0000000000000458. Review.

44.

Pain and the global burden of disease.

Rice AS, Smith BH, Blyth FM.

Pain. 2016 Apr;157(4):791-6. doi: 10.1097/j.pain.0000000000000454. Review. No abstract available.

PMID:
26670465
45.

Quantitative sensory testing using DFNS protocol in Europe: an evaluation of heterogeneity across multiple centers in patients with peripheral neuropathic pain and healthy subjects.

Vollert J, Attal N, Baron R, Freynhagen R, Haanpää M, Hansson P, Jensen TS, Rice AS, Segerdahl M, Serra J, Sindrup SH, Tölle TR, Treede RD, Maier C.

Pain. 2016 Mar;157(3):750-8. doi: 10.1097/j.pain.0000000000000433.

PMID:
26630440
46.

Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations.

van Hecke O, Kamerman PR, Attal N, Baron R, Bjornsdottir G, Bennett DL, Bennett MI, Bouhassira D, Diatchenko L, Freeman R, Freynhagen R, Haanpää M, Jensen TS, Raja SN, Rice AS, Seltzer Z, Thorgeirsson TE, Yarnitsky D, Smith BH.

Pain. 2015 Nov;156(11):2337-53. doi: 10.1097/j.pain.0000000000000335. Review. Erratum in: Pain. 2017 Jun;158(6):1180.

47.

Oral nonsteroidal anti-inflammatory drugs for neuropathic pain.

Moore RA, Chi CC, Wiffen PJ, Derry S, Rice AS.

Cochrane Database Syst Rev. 2015 Oct 5;(10):CD010902. doi: 10.1002/14651858.CD010902.pub2. Review.

PMID:
26436601
48.

Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.

Miller CH, Rice AS, Boylan B, Payne AB, Kelly FM, Escobar MA, Gill J, Leissinger C, Soucie JM; Hemophilia Inhibitor Research Study Investigators.

Am J Hematol. 2015 Oct;90(10):871-6. doi: 10.1002/ajh.24104. Epub 2015 Sep 10.

49.

Who is healthy? Aspects to consider when including healthy volunteers in QST--based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia.

Gierthmühlen J, Enax-Krumova EK, Attal N, Bouhassira D, Cruccu G, Finnerup NB, Haanpää M, Hansson P, Jensen TS, Freynhagen R, Kennedy JD, Mainka T, Rice AS, Segerdahl M, Sindrup SH, Serra J, Tölle T, Treede RD, Baron R, Maier C.

Pain. 2015 Nov;156(11):2203-11. doi: 10.1097/j.pain.0000000000000227.

PMID:
26075963
50.

Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy.

Dinat N, Marinda E, Moch S, Rice AS, Kamerman PR.

PLoS One. 2015 May 14;10(5):e0126297. doi: 10.1371/journal.pone.0126297. eCollection 2015.

Supplemental Content

Support Center